Latest News
Press Releases
December 3, 2020
IAVI Announces Launch of EDCTP-funded Socio-behavioral Project on Accessible HIV Prevention Tools for African Women
October 29, 2020IAVI Announces Start of Clinical Trial of Next-Generation HIV Vaccine Candidate
October 27, 2020Support from the U.S. Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says
October 22, 2020IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
August 10, 2020IAVI and Wellcome issue a global call to action: Monoclonal antibodies for COVID-19 and other diseases could save millions of lives
Features
April 10, 2021
Media Roundup: News Coverage Highlights Preliminary Data from IAVI G001 Clinical Trial
April 2, 2021Donor Spotlight: Government of India
March 29, 2021Eradicating TB is achievable but only if we show the same commitment that we did for COVID-19
March 24, 2021Uhambo: Twists and turns on the journey to an efficacious HIV-1 vaccine
March 12, 2021Innovative bio-therapeutics for COVID-19: How can monoclonal antibodies for SARS-CoV-2 be made accessible in LMICs?
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
